2m 2m 2m 2m 2m 2m 2m
Editas Medicine (EDIT)
NASDAQ
$2.72-$0.04 (-1.38%)
Price as of Jun 23, 2026 7:59 PM EDT- $429.7MMarket Cap
- 22.67%1-Year Change
- BiotechnologyIndustry
Editas Medicine (EDIT)
$2.72-$0.04 (-1.38%)
EDIT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.76 | ||
Change | +$0.11 (+4.09%) | ||
Open | $2.72 | ||
High | $2.91 | ||
Low | $2.72 | ||
Previous Close | $2.80 | ||
Volume | 1,991,736 | ||
30-Day Average Volume | 3,880,318 | ||
1-Week Change | 13.82% | ||
1-Month Change | 1.45% | ||
1-Year Change | 33.33% | ||
3-Year Change | -65.09% | ||
5-Year Change | -92.31% | ||
Fundamentals | |||
Shares Outstanding | 153.5M | ||
Total Assets | $149.3M | ||
Market Cap | $429.7M | ||
Enterprise Value | $360.7M | ||
Period: QTR TTM FY | |||
Revenue | $2.8M | ||
Net Income | -$25.0M | ||
Free Cash Flow | -$23.2M | ||
EBIT | -$23.9M | ||
EBITDA | -$23.4M | ||
Net Working Capital | $88.3M | ||
EPS | -$0.26 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | 127 | ||
P/B | 97 | ||
P/E | -11 | ||
PEG | 0 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue